Minimally invasive esophagectomy for benign disease.
MIE can provide patients with reduced morbidity and a rapid recovery in the treatment of benign conditions. There is few data examining the long-term outcomes of MIE specifically in the context of benign disease. At present, MIE should be performed in centers with experience in advanced minimally invasive esophageal surgery, and it requires a team approach. Multicenter, prospective randomized controlled trials will be required to determine the superiority of MIE compared with open esophagectomy. Further investigation will be required to determine the effect of MIE on quality of life and long-term outcomes in the treatment of benign conditions.